The landscape of oncology has been forever changed by the emergence of Chimeric Antigen Receptor (CAR) T cell therapy. This groundbreaking immunotherapy, which involves re-engineering a patient’s own immune cells to recognize and attack cancer, is no longer a futuristic concept—it is a clinical reality. As researchers push the boundaries of biotechnology, the global CAR T Cell...